Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance.

Autophagy is a catabolic process activated by stress conditions and nutrient deprivation, to which it reacts by promoting the degradation of damaged organelles and misfolded/aggregated proteins, as well as generating new energetic pools. Paradoxically, in cancer cells, which signal the dangerous microenvironment occurring during clinical therapies, autophagy could promote their proliferation and sustain drug resistance. Special attention is given to autophagy manipulation in order to counteract drug resistance of cancer cells. This article describes the basic properties of autophagy and focuses on the strategies of manipulating it.

[1]  Kevin M. Ryan,et al.  DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis , 2006, Cell.

[2]  J. Rutter,et al.  Ubiquitin-dependent mitochondrial protein degradation. , 2011, The international journal of biochemistry & cell biology.

[3]  D. Guarnieri,et al.  MicroRNAs: A new class of gene regulators , 2008, Annals of medicine.

[4]  J. Brugge,et al.  The cell biology of cell-in-cell structures , 2008, Nature Reviews Molecular Cell Biology.

[5]  Bo Zhou,et al.  3,4‐dimethoxystilbene, a resveratrol derivative with anti‐angiogenic effect, induces both macroautophagy and apoptosis in endothelial cells , 2013, Journal of cellular biochemistry.

[6]  K. Chowdhury,et al.  The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.

[7]  A. Thorburn,et al.  Autophagy Inhibition for Chemosensitization and Radiosensitization in Cancer: Do the Preclinical Data Support This Therapeutic Strategy? , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[8]  Y. Takahashi,et al.  Bif-1/Endophilin B1: a candidate for crescent driving force in autophagy , 2009, Cell Death and Differentiation.

[9]  Daniel J. Klionsky,et al.  Autophagy: from phenomenology to molecular understanding in less than a decade , 2007, Nature Reviews Molecular Cell Biology.

[10]  Y. Doki,et al.  LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. , 2008, International journal of oncology.

[11]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[12]  Yongqiang Chen,et al.  The regulation of autophagy – unanswered questions , 2011, Journal of Cell Science.

[13]  P. Cossart,et al.  Selective autophagy degrades DICER and AGO2 and regulates miRNA activity , 2012, Nature Cell Biology.

[14]  J. Cleveland,et al.  Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. , 2007, Blood.

[15]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[16]  I. Amelio,et al.  Cell death pathology: cross-talk with autophagy and its clinical implications. , 2011, Biochemical and biophysical research communications.

[17]  K. Qin,et al.  Rapamycin Delays Disease Onset and Prevents PrP Plaque Deposition in a Mouse Model of Gerstmann–Sträussler–Scheinker Disease , 2012, The Journal of Neuroscience.

[18]  S. Ramakrishnan,et al.  Autophagy and Angiogenesis Inhibition , 2007, Autophagy.

[19]  C. Thompson,et al.  Therapeutic targets in cancer cell metabolism and autophagy , 2012, Nature Biotechnology.

[20]  Ivan Dikic,et al.  A role for ubiquitin in selective autophagy. , 2009, Molecular cell.

[21]  John L Cleveland,et al.  Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. , 2008, The Journal of clinical investigation.

[22]  J. Ju,et al.  MicroRNA: a third dimension in autophagy. , 2013, Cell cycle.

[23]  Z. Zong,et al.  Beclin 1 enhances proteasome inhibition-mediated cytotoxicity of thyroid cancer cells in macroautophagy-independent manner. , 2013, The Journal of clinical endocrinology and metabolism.

[24]  Marta Martínez-Vicente,et al.  Fighting neurodegeneration with rapamycin: mechanistic insights , 2011, Nature Reviews Neuroscience.

[25]  Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors , 2012, Cell Death and Disease.

[26]  D. Rubinsztein.  Autophagy—alias self‐eating—appetite and ageing , 2012, EMBO reports.

[27]  A. Wen,et al.  Autophagy is a therapeutic target in anticancer drug resistance. , 2010, Biochimica et biophysica acta.

[28]  Zhi-Min Yuan,et al.  Modulation of autophagic activity by extracellular pH , 2011, Autophagy.

[29]  P. Matarrese,et al.  Xeno-cannibalism as an exacerbation of self-cannibalism: a possible fruitful survival strategy for cancer cells. , 2008, Current pharmaceutical design.

[30]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[31]  S. Amin,et al.  Autophagosomal Membrane Serves as Platform for Intracellular Death-inducing Signaling Complex (iDISC)-mediated Caspase-8 Activation and Apoptosis* , 2012, The Journal of Biological Chemistry.

[32]  G. Kroemer,et al.  Mitochondrial liaisons of p53. , 2011, Antioxidants & redox signaling.

[33]  D. Green,et al.  Apoptosis and cancer. , 1994, Important advances in oncology.

[34]  D. Rubinsztein,et al.  Autophagy and polyglutamine diseases , 2012, Progress in Neurobiology.

[35]  D. Rubinsztein,et al.  Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.

[36]  Jie Xu,et al.  Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells , 2012, Autophagy.

[37]  Mei Lan Tan,et al.  Apoptosis and Cancer , 2020, Cancer Immunology.

[38]  G. Fimia,et al.  Regulation of autophagy in mammals and its interplay with apoptosis , 2010, Cellular and Molecular Life Sciences.

[39]  D. Quinn,et al.  Differentiating mTOR inhibitors in renal cell carcinoma. , 2013, Cancer treatment reviews.

[40]  D. Stolz,et al.  Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy , 2009, Molecular Cancer Therapeutics.

[41]  Di Chen,et al.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. , 2011, Current cancer drug targets.

[42]  Thomas Schaffner,et al.  Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis , 2006, Nature Cell Biology.

[43]  K. Norga,et al.  Autophagy and phagocytosis-like cell cannibalism exert opposing effects on cellular survival during metabolic stress , 2012, Cell Death and Differentiation.

[44]  G. Mazzini,et al.  Killing of tumor cells: a drama in two acts. , 2011, Biochemical pharmacology.

[45]  M. Mimeault,et al.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells , 2013, Journal of cellular and molecular medicine.

[46]  J. Pouysségur,et al.  Hypoxia-induced autophagy: cell death or cell survival? , 2010, Current opinion in cell biology.

[47]  A. Scovassi,et al.  Autophagy and Cancer , 2012, Cells.

[48]  M. Donadelli,et al.  Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis , 2012, Apoptosis.

[49]  A. Sood,et al.  Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Min Sung Kim,et al.  Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. , 2008, Human pathology.

[51]  M. Djavaheri-Mergny,et al.  The complex interplay between autophagy and NF-κB signaling pathways in cancer cells. , 2011, American journal of cancer research.

[52]  W. Yung,et al.  NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas , 2009, Molecular Cancer Therapeutics.

[53]  B. Evers,et al.  mTOR inhibitors in cancer therapy. , 2012, Cancer letters.

[54]  L. Avery,et al.  To be or not to be, the level of autophagy is the question: Dual roles of autophagy in the survival response to starvation , 2008, Autophagy.

[55]  N. Yoo,et al.  Frameshift mutations of autophagy‐related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability , 2009, The Journal of pathology.

[56]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[57]  S. Ramakrishnan,et al.  Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. , 2007, Blood.

[58]  A. Lund,et al.  MicroRNA regulation of autophagy. , 2012, Carcinogenesis.

[59]  S. Minucci,et al.  Acetylation: a novel link between double-strand break repair and autophagy. , 2012, Cancer research.

[60]  J. Debnath,et al.  Autophagy and tumorigenesis , 2010, FEBS letters.

[61]  Zhen-hua Hu,et al.  Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors , 2012, BMC Cancer.

[62]  Simon Tavaré,et al.  Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.

[63]  M. Overholtzer,et al.  Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism. , 2012, Cancer research.

[64]  G. Kroemer,et al.  Autophagy for tissue homeostasis and neuroprotection. , 2011, Current opinion in cell biology.

[65]  A. Cuervo,et al.  Autophagy and disease: always two sides to a problem , 2012, The Journal of pathology.

[66]  H. Kluger,et al.  Studies of NVP-BEZ235 in melanoma. , 2013, Current cancer drug targets.

[67]  W. Gu,et al.  The impact of acetylation and deacetylation on the p53 pathway , 2011, Protein & Cell.

[68]  A. Scovassi,et al.  Apoptosis: a way to maintain healthy individuals. , 2010, Sub-cellular biochemistry.

[69]  N. Mizushima,et al.  Autophagy in mammalian development and differentiation , 2010, Nature Cell Biology.

[70]  P. Dey,et al.  Cell cannibalism and cancer , 2010, Diagnostic cytopathology.

[71]  Thomas C. Chen,et al.  Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. , 2012, Cancer letters.

[72]  R. Crazzolara,et al.  Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia. , 2009, Blood.

[73]  C. Franceschi,et al.  Survival features of EBV-stabilized cells from centenarians: morpho-functional and transcriptomic analyses , 2011, AGE.

[74]  A. Wellstein,et al.  Dietary downregulation of mutant p53 levels via glucose restriction , 2012, Cell cycle.

[75]  Jeremy M. Stark,et al.  A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. , 2012, Developmental cell.

[76]  L. Platanias,et al.  Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies , 2011, Current opinion in oncology.

[77]  D. Klionsky,et al.  Regulation mechanisms and signaling pathways of autophagy. , 2009, Annual review of genetics.

[78]  H. Koh,et al.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity , 2012, Molecules and cells.

[79]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[80]  Virginia Todde,et al.  Autophagy: principles and significance in health and disease. , 2009, Biochimica et biophysica acta.

[81]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[82]  T. Vellai,et al.  Janus-Faced Autophagy: A Dual Role of Cellular Self-Eating in Neurodegeneration? , 2007, Autophagy.

[83]  S. Mendrinos,et al.  Patterns of autophagy in urothelial cell carcinomas--the significance of "stone-like" structures (SLS) in transurethral resection biopsies. , 2013, Urologic oncology.

[84]  Vincent W. Li,et al.  Cancer prevention by targeting angiogenesis , 2012, Nature Reviews Clinical Oncology.

[85]  I. El-Sherbiny,et al.  Formulation approaches to short interfering RNA and MicroRNA: challenges and implications. , 2012, Journal of pharmaceutical sciences.

[86]  D. McConkey,et al.  HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer. , 2012, Advances in cancer research.

[87]  R. Xavier,et al.  A systems biology viewpoint on autophagy in health and disease , 2010, Current opinion in gastroenterology.

[88]  P. Codogno,et al.  Autophagic cell death: Loch Ness monster or endangered species? , 2011, Autophagy.

[89]  R. Kurzrock,et al.  Autophagy as a target for anticancer therapy , 2011, Nature Reviews Clinical Oncology.

[90]  W. Wu,et al.  The autophagic paradox in cancer therapy , 2012, Oncogene.

[91]  Anna M. Krichevsky,et al.  Context effect: microRNA-10b in cancer cell proliferation, spread and death , 2011, Autophagy.

[92]  M. Oren,et al.  p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation , 2010, Proceedings of the National Academy of Sciences.

[93]  P Vernon,et al.  Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells , 2012, Leukemia.

[94]  Yun Chen,et al.  Pro- and Anti-angiogenesis Effects of Resveratrol , 2007 .

[95]  E. Solary,et al.  Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. , 2011, Current medicinal chemistry.

[96]  O. Surova,et al.  Various modes of cell death induced by DNA damage , 2013, Oncogene.

[97]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[98]  L. Mayo.  Directing p53 to induce autophagy , 2012, Cell cycle.

[99]  A. Tsung,et al.  miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. , 2012, Gastroenterology.

[100]  D. Massi,et al.  Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. , 2010, Human pathology.

[101]  Wei Gu,et al.  p53 post-translational modification: deregulated in tumorigenesis. , 2010, Trends in molecular medicine.

[102]  N. Ip,et al.  Molecular machinery of macroautophagy and its deregulation in diseases. , 2011, Biochimica et biophysica acta.

[103]  N. Denko,et al.  Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L , 2008, Cell Death and Differentiation.

[104]  S. Comincini,et al.  Autophagy and ionizing radiation in tumors: The “survive or not survive” dilemma , 2013, Journal of cellular physiology.

[105]  C. James,et al.  Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma , 2010, Science Signaling.

[106]  S. Fulda,et al.  The dual PI3K/mTOR inhibitor NVP‐BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial‐lysosomal cross‐talk , 2013, International journal of cancer.

[107]  E. Zalckvar,et al.  Systems biology analysis of programmed cell death. , 2010, Trends in biochemical sciences.

[108]  J. Folkman.  Angiogenesis: an organizing principle for drug discovery? , 2007, Nature reviews. Drug discovery.

[109]  F. Cecconi,et al.  Unleashing the Ambra1-Beclin 1 complex from dynein chains: Ulk1 sets Ambra1 free to induce autophagy , 2011, Autophagy.

[110]  Yuquan Wei,et al.  Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde? , 2012, Cancer letters.

[111]  M. Rebucci,et al.  Molecular aspects of cancer cell resistance to chemotherapy. , 2013, Biochemical pharmacology.

[112]  Yan G Zhao,et al.  The p53-induced Gene Ei24 Is an Essential Component of the Basal Autophagy Pathway* , 2012, The Journal of Biological Chemistry.

[113]  J. Carew,et al.  Autophagy as a target for cancer therapy: new developments , 2012, Cancer management and research.

[114]  H. Virgin,et al.  Autophagy in immunity and inflammation , 2011, Nature.

[115]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[116]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[117]  K. Dalby,et al.  Targeting the pro-death and pro-survival functions of autophagy as novel therapeutic strategies in cancer , 2010, Autophagy.

[118]  F. Cecconi.  Autophagy regulation by miRNAs: when cleaning goes out of service , 2011, The EMBO journal.

[119]  S. Minucci,et al.  HDACs link the DNA damage response, processing of double-strand breaks and autophagy , 2011, Nature.

[120]  A. Scovassi,et al.  Conversation between apoptosis and autophagy: “Is it your turn or mine?” , 2011, Apoptosis.

[121]  J. Kim,et al.  Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. , 2009, Cancer letters.

[122]  Sharad Kumar,et al.  Cell death by autophagy: facts and apparent artefacts , 2011, Cell Death and Differentiation.

[123]  D. Klionsky,et al.  Autophagosome formation: core machinery and adaptations , 2007, Nature Cell Biology.

[124]  M. J. Clague,et al.  Ubiquitin: Same Molecule, Different Degradation Pathways , 2010, Cell.

[125]  A. Scovassi.  Defective Apoptosis and Efficient Autophagy: Two Ways to Protect Cancer Cells from Death , 2012 .

[126]  P. Vandenabeele,et al.  Molecular mechanisms of necroptosis: an ordered cellular explosion , 2010, Nature Reviews Molecular Cell Biology.

[127]  A. Krogh,et al.  microRNA‐101 is a potent inhibitor of autophagy , 2011, The EMBO journal.

[128]  Xiuping Liu,et al.  Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells , 2009, Autophagy.

[129]  K. Kersse,et al.  Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria , 2010, Cell Death and Disease.

[130]  E. Morselli,et al.  Life, death and burial: multifaceted impact of autophagy. , 2008, Biochemical Society transactions.

[131]  M. Aghi,et al.  Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy , 2012, Autophagy.

[132]  P. Marks,et al.  Curbing autophagy and histone deacetylases to kill cancer cells , 2012, Autophagy.

[133]  G. Kroemer,et al.  Bcl-2 family members: dual regulators of apoptosis and autophagy. , 2008, Autophagy.

[134]  L. Platanias,et al.  The evolution of the TOR pathway and its role in cancer , 2013, Oncogene.

[135]  R. Amaravadi,et al.  Autophagy: a targetable linchpin of cancer cell metabolism , 2013, Trends in Endocrinology & Metabolism.

[136]  Edward M. Johnson.  The fox and the fat , 2012, Cell cycle.

[137]  Xiaofeng Jiang,et al.  Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid Cancer , 2010, Molecular Cancer Research.

[138]  Xiangjun Liu,et al.  Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors , 2010, BMC Cancer.

[139]  A. Giaccia,et al.  Targeting cancer cells through autophagy for anticancer therapy. , 2010, Current opinion in cell biology.

[140]  Xinbing Sui,et al.  p53 signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment , 2011, Autophagy.

[141]  K. Ryan.  p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. , 2011, European journal of cancer.

[142]  D. Gewirtz,et al.  Autophagy, senescence, and apoptosis. , 2013, Methods in molecular biology.

[143]  B. Levine,et al.  Cell biology: Autophagy and cancer , 2007, Nature.

[144]  C. Lengerke,et al.  Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development , 2013, Journal of cellular and molecular medicine.

[145]  V. Karantza,et al.  The interplay between autophagy and ROS in tumorigenesis , 2012, Front. Oncol..

[146]  C. Sessa,et al.  Targeting mTOR pathways in human malignancies. , 2012, Current pharmaceutical design.

[147]  Zhongyu Yuan,et al.  Decreased expression of light chain 3 (LC3) increased the risk of distant metastasis in triple-negative breast cancer , 2013, Medical Oncology.

[148]  Qing Jun Wang,et al.  The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. , 2010, Trends in cell biology.

[149]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[150]  Nektarios Tavernarakis,et al.  Regulation of autophagy by cytoplasmic p53 , 2008, Nature Cell Biology.

[151]  P. Genschik,et al.  Degradation of the antiviral component ARGONAUTE1 by the autophagy pathway , 2012, Proceedings of the National Academy of Sciences.

[152]  C. Plass,et al.  miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. , 2012, Cancer research.

[153]  M. Jäättelä,et al.  Apoptosis and autophagy: Targeting autophagy signalling in cancer cells –‘trick or treats’? , 2009, The FEBS journal.

[154]  N. Ktistakis,et al.  Autophagosome formation in mammalian cells , 2010, Seminars in Immunopathology.

[155]  Andrew L. Lee,et al.  Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate. , 2011, Journal of molecular biology.

[156]  S. Gygi,et al.  Network organization of the human autophagy system , 2010, Nature.

[157]  A. Kimmelman,et al.  The dynamic nature of autophagy in cancer. , 2011, Genes & development.

[158]  Xiaodong Liu,et al.  MicroRNA-18a upregulates autophagy and ataxia telangiectasia mutated gene expression in HCT116 colon cancer cells. , 2013, Molecular medicine reports.

[159]  R. Abraham,et al.  Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. , 2010, Cancer research.

[160]  C. Watson,et al.  Killing a cancer: what are the alternatives? , 2012, Nature Reviews Cancer.

[161]  J. Driscoll,et al.  Molecular crosstalk between the proteasome, aggresomes and autophagy: translational potential and clinical implications. , 2012, Cancer letters.

[162]  D. Camidge,et al.  Targeted manipulation of apoptosis in cancer treatment. , 2008, The Lancet. Oncology.

[163]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[164]  Ajit S. Narang,et al.  Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA , 2011, Pharmaceutical Research.

[165]  William A Weiss,et al.  Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.

[166]  R. Agami,et al.  miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1 , 2012, Autophagy.

[167]  Kay Hofmann,et al.  Selective autophagy: ubiquitin-mediated recognition and beyond , 2010, Nature Cell Biology.

[168]  T. Weichhart.  Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. , 2012, Methods in molecular biology.

[169]  T. P. Neufeld,et al.  TOR-dependent control of autophagy: biting the hand that feeds. , 2010, Current opinion in cell biology.

[170]  Brian K. Kennedy,et al.  TOR on the brain , 2011, Experimental Gerontology.

[171]  K. Schlie,et al.  Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity , 2012, Immunological reviews.

[172]  F. Xue,et al.  Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. , 2012, Biochemical and biophysical research communications.

[173]  Bo Liu,et al.  MicroRNA-modulated autophagic signaling networks in cancer. , 2012, The international journal of biochemistry & cell biology.